This work was supported by the National Institutes of Health (CA-28824). F.Y. is a Uehara Memorial Foundation Fellow. A.R. is a NIH Cancer Pharmacology Fellow (T32-CA62948). A.E.G. is a MSKCC Experimental Therapeutics Center Fellow. We thank Ms. Sylvi Rusli (NMR Core Facility, CA-02848) and Mrs. Anna Dudkina for mass spectral analyses.
Communication
Synthesis and Conformational Analysis of (E)-9,10-Dehydroepothilone B: A Suggestive Link between the Chemistry and Biology of Epothilones†
Article first published online: 5 JUN 2003
DOI: 10.1002/anie.200351407
Copyright © 2003 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Additional Information
How to Cite
Yoshimura, F., Rivkin, A., Gabarda, A. E., Chou, T.-C., Dong, H., Sukenick, G., Morel, F. F., Taylor, R. E. and Danishefsky, S. J. (2003), Synthesis and Conformational Analysis of (E)-9,10-Dehydroepothilone B: A Suggestive Link between the Chemistry and Biology of Epothilones. Angew. Chem. Int. Ed., 42: 2518–2521. doi: 10.1002/anie.200351407
- †
Publication History
- Issue published online: 5 JUN 2003
- Article first published online: 5 JUN 2003
- Manuscript Received: 14 MAR 2003
Keywords:
- antitumor agents;
- conformational analysis;
- natural products;
- structure–activity relationships

The most potent epothilone analogue reported to date was obtained by incorporation of an E double bond at C9
C10 in the epothilone B series (see picture). Molecular modeling, NMR spectroscopic analysis, and chemical observations were used to rationalize the remarkable potency-enhancing effect of the double bond.

1521-3773/asset/2002_left.gif?v=1&s=ac6b0d94a94d7ce7a210002b8096b42feffc0bcf)
1521-3773/asset/2002_right.gif?v=1&s=451042aa3415ae3ad0729984d26dee1866aca82e)
